drugset / Trial / NCT04044703
Improving Dosing of Vancomycin in Young Infants With Infections
Phase 4
Completed
44 enrolled
Murdoch Childrens Research Institute
Monash Health · collabRoyal Children's Hospital · collabRoyal Hospital For Women · collabSydney Children's Hospitals Network · collabUniversity of Otago · collab
NaSingle-groupOpen-labelTreatment
Summary
Current dosing regimens for vancomycin result in many young infants not reaching the target level of vancomycin in the blood at steady state (when the blood is in equilibrium at 24-48 hours).The purpose of this study is to assess an improved method of calculating the dose of vancomycin ('model-based dosing') in young infants with infections in order for them to achieve the target vancomycin level at steady state. A dosing calculator (which will be available through a web application) will be used for the dose calculation.
Timeline
- Start
- 2019-08-30
- Primary completion
- 2020-12-29
- Completion
- 2021-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | — | Intravenous |